| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 03/27/2013 | CN103003430A Antisense molecules and methods for treating pathologies |
| 03/27/2013 | CN102994221A Method for extracting coix seed oil from coix seed |
| 03/27/2013 | CN102993277A Novel immunomodulatory protein, preparation method and application |
| 03/27/2013 | CN102993204A Certain chemical entities, compositions and methods |
| 03/27/2013 | CN102988995A Compositions and methods of topical application and transdermal delivery of botulinum toxins stabilized with polypeptide fragments derived from HIV-TAT |
| 03/27/2013 | CN102988959A Modulation of NKG2D |
| 03/27/2013 | CN102988957A Pharmaceutical compositions and methods of using secreted frizzled related protein |
| 03/27/2013 | CN102988919A Capsules for stopping hyperspasmia and spasm |
| 03/27/2013 | CN102988909A Rheumatoid bone rubbing wine |
| 03/27/2013 | CN102988787A Chinese herbal medicine for treating tetanus |
| 03/27/2013 | CN102988728A Chinese medicinal formulae for treating kidney deficiency type lumbar muscle degeneration |
| 03/27/2013 | CN102988668A TCM (Traditional Chinese medicine) prescription for treating qi stagnation and blood stasis type lumbar muscle degenerations |
| 03/27/2013 | CN102988642A Plaster for treating cervical spondylosis |
| 03/27/2013 | CN102988628A External medicament for treating cervical spondylosis |
| 03/27/2013 | CN102988565A Pang barrel medicated bath circulation blend type health care medicine bag and preparation method thereof |
| 03/27/2013 | CN102988539A Cherokee rose fruit tablets for astringing qi and relieving desertion |
| 03/27/2013 | CN102988338A Nitrate esters and their use for the treatment of muscle and muscle related diseases |
| 03/27/2013 | CN102988287A Process for preparing racanisodamine hydrochloride used for injection |
| 03/27/2013 | CN102366402B Scopolamine hydrobromide injection and production technology |
| 03/27/2013 | CN101921772B Human antibodies that bind human IL-12 and methods for producing |
| 03/27/2013 | CN101584869B Method of differentiating/inducing bone marrow interstitial cells into nerve cells and skeleton muscle cells by transferring notch gene |
| 03/27/2013 | CN101066997B Human antibodies that bind human IL-12 and methods for producing |
| 03/26/2013 | US8404226 Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs |
| 03/26/2013 | CA2463850C Remodeling of tissues and organs |
| 03/26/2013 | CA2457925C Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
| 03/21/2013 | WO2013040417A1 Amphiphilic cationic polymers for the delivery of therapeutic agents |
| 03/21/2013 | WO2013039244A1 Agent for promoting skeletal muscle regeneration |
| 03/21/2013 | WO2013039197A1 IκB KINASE α ACTIVATION INHIBITOR |
| 03/21/2013 | WO2013038740A1 Method for screening for substance or factor capable of promoting muscle hypertrophy |
| 03/21/2013 | US20130072541 Adeno-associated viral vector for exon skipping in a gene encoding a dispensible-domain protein |
| 03/21/2013 | US20130072522 Process for Making Modulators of Cystic Fibrosis Transmembrane Conductance Regulator |
| 03/21/2013 | US20130072517 Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders |
| 03/21/2013 | US20130072421 Treatment of sirtuin (sirt) related diseases by inhibition of natural antisense transcript to a sirtuin (sirt) |
| 03/21/2013 | US20130071320 Immunotherapy of autoimmune disorders using antibodies which target b-cells |
| 03/21/2013 | CA2848740A1 Amphiphilic cationic polymers for the delivery of therapeutic agents |
| 03/20/2013 | EP2570411A1 Nitrogen-containing heterocyclic compound having kynurenine production inhibitory activity |
| 03/20/2013 | EP2570136A2 Protein A compositions and methods of use |
| 03/20/2013 | EP2569016A1 Pharmaceutical compositions comprising antisense oligonucleotides and methods of using same |
| 03/20/2013 | EP2569004A2 Lactoferrin -based biomaterials for tissue regeneration and drug delivery |
| 03/20/2013 | EP2568999A2 Acth for treatment of amyotrophic lateral sclerosis |
| 03/20/2013 | CN1606554B Beta-lactamyl vasopressin v1a antagonists |
| 03/20/2013 | CN102985102A Non-diffusive botulinum toxin causing local muscle paralysis, and purification method thereof |
| 03/20/2013 | CN102985092A Synthesis of DGJNAc from D-glucuronolactone and use to inhibit alpha-N-acetylgalactosaminidases |
| 03/20/2013 | CN102977212A Compositions comprising anti-IGF-1r antibodies and methods for their production |
| 03/20/2013 | CN102976973A Selective androgen receptor modulator and method for using thereof |
| 03/20/2013 | CN102973714A Traditional Chinese medicine composition for treating lumbar muscle strain and preparation method thereof |
| 03/20/2013 | CN102973639A Cervical vertebra therapeutic medicine composition |
| 03/20/2013 | CN102002050B Bisbenzylisoquinoline derivative and preparation and application thereof |
| 03/20/2013 | CN101843653B Processing method of Chinese stellera root condensed decoction |
| 03/19/2013 | US8399520 Selective estrogen receptor modulator |
| 03/19/2013 | US8399457 Pharmaceutical compounds |
| 03/19/2013 | US8398998 Therapeutic composition comprising a botulinum neurotoxin |
| 03/19/2013 | CA2354638C Expression of secreted human alpha-fetoprotein in transgenic animals |
| 03/14/2013 | WO2013036875A1 Ceramidase and cell differentiation |
| 03/14/2013 | WO2013035712A1 Medicinal agent for treating amyotrophic lateral sclerosis or preventing progression of phase of amyotrophic lateral sclerosis |
| 03/14/2013 | WO2013035047A1 Benzothiazolone compound |
| 03/14/2013 | WO2012173581A4 Thiocolchicoside, etodolac and famotidine combinations |
| 03/14/2013 | US20130065899 Heteroaryl compounds and uses thereof |
| 03/14/2013 | US20130065886 Administration of benzodiazepine compositions |
| 03/14/2013 | US20130065823 Supplement for Strengthening the Muscles of a Human |
| 03/14/2013 | US20130065820 Synthetic myostatin peptide antagonists |
| 03/14/2013 | US20130065816 Analogs of pituitary adenylate cyclase-activating polypeptide (pacap) and methods for their use |
| 03/14/2013 | US20130064801 Cellular Compositions and Methods of Making and Using Them |
| 03/14/2013 | US20130064760 Method for Treating Crohn's Disease By Administering An Anti-IL-12 Antibody |
| 03/14/2013 | CA2847624A1 Pharmaceutical agent for treating amyotrophic lateral sclerosis or suppressing disease progress thereof |
| 03/14/2013 | CA2845766A1 Benzothiazolone compound |
| 03/13/2013 | CN202777137U Medicine health-care hand pillow |
| 03/13/2013 | CN102971318A Tetrahydrocarboline derivative |
| 03/13/2013 | CN102964349A Tosilate of benzodiazepine derivative, its crystal forms, their preparation method and application |
| 03/12/2013 | CA2569763C 2,4-diaminoquinazolines for spinal muscular atrophy |
| 03/12/2013 | CA2366865C Flupirtine in the treatment of fibromyalgia and related conditions |
| 03/07/2013 | WO2013031749A1 Lactic acid bacteria for promoting physical activity |
| 03/07/2013 | WO2013030569A2 Peptides |
| 03/07/2013 | WO2013029431A1 Benzodiazepine derivatives tosylate salts, their polymorphic forms, preparation methods and uses thereof |
| 03/07/2013 | US20130059920 Hydroxytyrosol benefits muscle differentiation and muscle contraction and relaxation |
| 03/07/2013 | US20130059902 Methods and compositions useful in treatment of diseases or conditions related to repeat expansion |
| 03/07/2013 | US20130059846 Compounds and compositions as c-kit kinase inhibitors |
| 03/07/2013 | US20130059835 Heterocyclylamines as pi3k inhibitors |
| 03/07/2013 | US20130059828 Pharmaceutical composition |
| 03/07/2013 | US20130059800 Pyrrolobenzodiazepines used to treat proliferative diseases |
| 03/07/2013 | US20130059779 Stabilized Insulin-like Growth Factor Polypeptides |
| 03/07/2013 | US20130058993 Methods and compositions for enhancing wound healing using car peptides |
| 03/07/2013 | US20130058972 Methods for regulating complement cascade proteins using astrovirus coat protein and derivatives thereof |
| 03/07/2013 | US20130058955 Anti-polyubiquitin antibodies and methods of use |
| 03/07/2013 | DE10213051B4 Substituierte 4-Aminocyclohexanole Substituted 4-aminocyclohexanols |
| 03/07/2013 | CA2846218A1 Peptides |
| 03/06/2013 | EP2564900A1 C-19 steroids for therapeutic uses |
| 03/06/2013 | CN102949695A Traditional Chinese medicine for treating intractable hiccough |
| 03/06/2013 | CN102949626A Pure Chinese medical composition for tonifying spleen and eliminating loss and preparation method thereof |
| 03/06/2013 | CN102949604A Specific medicine for controlling hiccup disease |
| 03/06/2013 | CN102949475A Preparation method of health care medicament |
| 03/06/2013 | CN102949404A Application of vanillic acid glucoside derivative in treatment of systemic autoimmune disease |
| 03/06/2013 | CN102949339A Rocuronium bromide-containing injection |
| 03/06/2013 | CN101993281B Culture medium of ganoderma capense (Lloyd) Teng fungus for preparing Baozhi glycopeptide injection |
| 03/06/2013 | CN101723939B Isopentenyl-oxyl substituted dehydrogenized silybin ether and preparation method and application thereof |
| 03/06/2013 | CN101623317B Serrate club moss oral disintegrating tablet and preparation method thereof |
| 03/05/2013 | US8389551 Optical enantiomers of phenyramidol and process for chiral synthesis |
| 03/05/2013 | US8389484 Methods for targeting RNA molecules |
| 03/05/2013 | US8388935 Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
| 03/05/2013 | CA2578250C Therapeutic composition with a botulinum neurotoxin |